LINICAL CO LTD is a Contract Research Organization (CRO) for Pharmaceutical Companies. The company specializes in Clinical Research Associate of Phase II and Phase III, while conducting other clinical trial related services such as Quality Management and Consulting.

(Delayed) 2nd Quarter Of Fy 2025 Financial Results Briefing

Summary Of Consolidated Financial Results For The Six Months Ended September 30, 2024 (Japanese Gaap)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Linical Co Ltd (2183 JP)

(Delayed) 2nd Quarter Of Fy 2025 Financial Results Briefing

Summary Of Consolidated Financial Results For The Six Months Ended September 30, 2024 (Japanese Gaap)

Notice Concerning A Revision Of The Results Forecast

Supplementary Information Of Consolidated Financial Results For The Three Months Ended June 30, 2024

Consolidated Financial Results For The Three Months Ended June 30, 2024 (Japanese Gaap)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)